Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01137877 · ClinicalTrials.gov registry record · Phase 3
Growth and Tolerance of Healthy Term Infants to a New Infant Formula
A Phase 3 study, sponsored by Abbott Nutrition.
- Terminated
- Registry status
- Phase 3
- Development phase
- 399
- Enrollment target
NCT01137877 is a Phase 3 study that was terminated before completion, run by Abbott Nutrition. The registered enrollment target is 399 participants.
The verdict
NCT01137877, a Phase 3 study, was terminated before completion, sponsored by Abbott Nutrition.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 399 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the effect of two experimental milk-based infant formulas on the growth and gastrointestinal (GI) tolerance of term infants.
Interventions
- OTHER Human Milk
- OTHER Milk based infant formula powder
- OTHER Investigational Infant Formula #1
- OTHER Investigational Infant Formula #2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01137877
The ClinicalTrials.gov registry entry for NCT01137877 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 399 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Human Milk is the first listed.
NCT01137877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01137877 about?
NCT01137877 is a clinical study titled "Growth and Tolerance of Healthy Term Infants to a New Infant Formula". The objective of this study is to evaluate the effect of two experimental milk-based infant formulas on the growth and gastrointestinal (GI) tolerance of term infants.
What is the current status of trial NCT01137877?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 399 participants. The study started on 2010-05. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01137877?
The interventions under investigation include: Human Milk (OTHER), Milk based infant formula powder (OTHER), Investigational Infant Formula #1 (OTHER), Investigational Infant Formula #2 (OTHER).
Who is sponsoring clinical trial NCT01137877?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.